OpenVSafe by OpenVAERS
Search V-safe

ZSA-21677-72639

2 vaccinations 0 coded responses 8 check-ins 0 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
207 / MD
Registered
2021-04-15
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-15
    Registered in v-safe
  4. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    no matching call case
  6. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2021-04-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-16 priority 2/3
2021-04-17 priority 2/3
2021-04-18 priority 2/3

1 report(s) with no call case — see the timeline.

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.

Loading…